Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,857 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.
Provenzano R, Szczech L, Leong R, Saikali KG, Zhong M, Lee TT, Little DJ, Houser MT, Frison L, Houghton J, Neff TB. Provenzano R, et al. Among authors: zhong m. Clin J Am Soc Nephrol. 2021 Aug;16(8):1190-1200. doi: 10.2215/CJN.16191020. Clin J Am Soc Nephrol. 2021. PMID: 34362786 Free PMC article.
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.
Besarab A, Chernyavskaya E, Motylev I, Shutov E, Kumbar LM, Gurevich K, Chan DT, Leong R, Poole L, Zhong M, Saikali KG, Franco M, Hemmerich S, Yu KH, Neff TB. Besarab A, et al. Among authors: zhong m. J Am Soc Nephrol. 2016 Apr;27(4):1225-33. doi: 10.1681/ASN.2015030241. Epub 2015 Oct 22. J Am Soc Nephrol. 2016. PMID: 26494833 Free PMC article. Clinical Trial.
Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.
Provenzano R, Fishbane S, Szczech L, Leong R, Saikali KG, Zhong M, Lee TT, Houser MT, Frison L, Houghton J, Little DJ, Peony Yu KH, Neff TB. Provenzano R, et al. Among authors: zhong m. Kidney Int Rep. 2020 Dec 24;6(3):613-623. doi: 10.1016/j.ekir.2020.12.018. eCollection 2021 Mar. Kidney Int Rep. 2020. Retraction in: Kidney Int Rep. 2022 Feb 05;7(3):665. doi: 10.1016/j.ekir.2022.01.1069 PMID: 33732976 Free PMC article. Retracted.
Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." Kidney Int Rep. 2021;6:613-623.
Provenzano R, Fishbane S, Szczech L, Leong R, Saikali KG, Zhong M, Lee TT, Houser MT, Frison L, Houghton J, Little DJ, Peony Yu KH, Neff TB. Provenzano R, et al. Among authors: zhong m. Kidney Int Rep. 2022 Feb 5;7(3):665. doi: 10.1016/j.ekir.2022.01.1069. eCollection 2022 Mar. Kidney Int Rep. 2022. PMID: 35257087 Free PMC article.
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.
Richeldi L, Fernández Pérez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G. Richeldi L, et al. Among authors: zhong m. Lancet Respir Med. 2020 Jan;8(1):25-33. doi: 10.1016/S2213-2600(19)30262-0. Epub 2019 Sep 28. Lancet Respir Med. 2020. PMID: 31575509 Clinical Trial.
3,857 results